Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen A Fletcher

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
Vaccine|December 26, 2012
Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal deliveryJoel Meyer, Stephanie A Harris, Iman Satti, et al.
Plos One|September 3, 2011
Th1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel Mycobacterium tuberculosis vaccine MVA85AKristin L Griffiths, Ansar A Pathan, Angela M Minassian, et al.
Vaccine|July 14, 2012
Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adultsAnsar A Pathan, Angela M Minassian, Clare R Sander, et al.
The Lancet. Infectious Diseases|July 28, 2006
Early clinical trials with a new tuberculosis vaccine, MVA85A, in tuberculosis-endemic countries: issues in study designHannah B Ibanga, Roger H Brookes, Philip C Hill, et al.
Frontiers in Immunology|May 21, 2019
<i>In vitro</i> Mycobacterial Growth Inhibition in South Korean Adults With Latent TB InfectionHyejon Lee, Jungho Kim, Young Ae Kang, et al.
Frontiers in Immunology|October 28, 2021
Characterization of the Infant Immune System and the Influence and Immunogenicity of BCG Vaccination in Infant and Adult Rhesus MacaquesCharlotte Sarfas, Andrew D White, Laura Sibley, et al.
Plos One|October 25, 2007
Boosting BCG with recombinant modified vaccinia ankara expressing antigen 85A: different boosting intervals and implications for efficacy trialsAnsar A Pathan, Clare R Sander, Helen A Fletcher, et al.
Vaccine|August 7, 2008
Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF-beta1Helen A Fletcher, Ansar A Pathan, Tamara K Berthoud, et al.
Open Biology|June 24, 2016
Systematic tracking of altered haematopoiesis during sporozoite-mediated malaria development reveals multiple response pointsMaria L Vainieri, Andrew M Blagborough, Adam L MacLean, et al.
Frontiers in Immunology|January 31, 2020
Tools for Assessing the Protective Efficacy of TB Vaccines in Humans: <i>in vitro</i> Mycobacterial Growth Inhibition Predicts Outcome of <i>in vivo</i> Mycobacterial InfectionRachel Tanner, Iman Satti, Stephanie A Harris, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Vaccine|December 26, 2012
Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal deliveryJoel Meyer, Stephanie A Harris, Iman Satti, et al.
Plos One|September 3, 2011
Th1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel Mycobacterium tuberculosis vaccine MVA85AKristin L Griffiths, Ansar A Pathan, Angela M Minassian, et al.
Vaccine|July 14, 2012
Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adultsAnsar A Pathan, Angela M Minassian, Clare R Sander, et al.
The Lancet. Infectious Diseases|July 28, 2006
Early clinical trials with a new tuberculosis vaccine, MVA85A, in tuberculosis-endemic countries: issues in study designHannah B Ibanga, Roger H Brookes, Philip C Hill, et al.
Frontiers in Immunology|May 21, 2019
<i>In vitro</i> Mycobacterial Growth Inhibition in South Korean Adults With Latent TB InfectionHyejon Lee, Jungho Kim, Young Ae Kang, et al.
Frontiers in Immunology|October 28, 2021
Characterization of the Infant Immune System and the Influence and Immunogenicity of BCG Vaccination in Infant and Adult Rhesus MacaquesCharlotte Sarfas, Andrew D White, Laura Sibley, et al.
Plos One|October 25, 2007
Boosting BCG with recombinant modified vaccinia ankara expressing antigen 85A: different boosting intervals and implications for efficacy trialsAnsar A Pathan, Clare R Sander, Helen A Fletcher, et al.
Vaccine|August 7, 2008
Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF-beta1Helen A Fletcher, Ansar A Pathan, Tamara K Berthoud, et al.
Open Biology|June 24, 2016
Systematic tracking of altered haematopoiesis during sporozoite-mediated malaria development reveals multiple response pointsMaria L Vainieri, Andrew M Blagborough, Adam L MacLean, et al.
Frontiers in Immunology|January 31, 2020
Tools for Assessing the Protective Efficacy of TB Vaccines in Humans: <i>in vitro</i> Mycobacterial Growth Inhibition Predicts Outcome of <i>in vivo</i> Mycobacterial InfectionRachel Tanner, Iman Satti, Stephanie A Harris, et al.
Pageof 9